Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/6/24 → 3/6/26 |
Funding
- Genmab US Incorporated: $27,556.00
23-MULTI-64-GUI-PMC (GCT1042-01): A First-in-Human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety and Anti-tumor Activity of GEN1042 in Subjects With Malignant Solid Tumors
- Arnold, Susanne M (PI)